Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.23.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning Balance at Dec. 31, 2021 $ 657,152 $ 3,007 $ 752,343 $ 225 $ (98,423)
Beginning Balance , Shares at Dec. 31, 2021   300,120,451      
Stock-based compensation expense 5,519   5,519    
Exercise of stock options 1,326 $ 15 1,311    
Exercise of stock options , Shares   1,486,727      
Gain on interest rate swap 1,869     1,869  
Net income 35,488       35,488
Ending Balance at Mar. 31, 2022 701,354 $ 3,022 759,173 $ 2,094 (62,935)
Ending Balance , Shares at Mar. 31, 2022   301,607,178      
Beginning Balance at Dec. 31, 2022 801,128 $ 3,072 783,579   14,477
Beginning Balance , Shares at Dec. 31, 2022   306,626,530      
Stock-based compensation expense 5,361   5,361    
Vesting of restructed stock units   $ 0 0    
Vesting of restructed stock units, Shares   4,296      
Exercise of stock options $ 1,116 $ 15 1,101    
Exercise of stock options , Shares 1,434,504 1,471,021      
Gain on interest rate swap $ 0        
Net income 21,136       21,136
Ending Balance at Mar. 31, 2023 $ 828,741 $ 3,087 $ 790,041   $ 35,613
Ending Balance , Shares at Mar. 31, 2023   308,101,847